Argus analyst David Toung raised the firm’s price target on Cencora (COR) to $280 from $270 and keeps a Buy rating on the shares. The company delivered strong results for Q1 and expects topline ...

Cencora, formerly known as AmerisourceBergen, is one of the Big 3 drug distributors alongside peers McKesson Corporation (MCK) and Cardinal Health, Inc. (CAH). It provides pharmaceutical ...

Moody's downgrades Walgreens outlook to negative Judge orders Walgreens to pay nearly $1 billion in COVID test case Walgreens injecting $300M in another Cencora sell-off, early settlement ...

Boomi has launched a comprehensive API Management (APIM) solution, which it says will help curb application programming interface (API) “sprawl” in organizations. In a statement, Boomi said the new ...

Cencora has a solid industry position in an oligopolistic market with supernormal return ratios and solid stock price returns. 1QFY25 results, as well as the near-term outlook, are also solid ...

Cencora, Danaher and McKesson. He also holds stock in tech companies Alphabet, Amazon, Apple, Meta, Microsoft and Nvidia as well as healthcare startups. His assets are worth anywhere from $95 ...

BERLIN, GERMANY - MAY 14: Confusion of different colored ethernet cables at a Server Cabinet in a ... [+] laboratory of Thales Germany on May 14, 2014 in Berlin, Germany. (Photo by Michael ...

But on the bright side, you can make far more than 100% on a really good stock. Long term Cencora, Inc. (NYSE:COR) shareholders would be well aware of this, since the stock is up 156% in five years.

Dimitra has an AI- and IoT-based app for farmers and cooperatives to track the conditions of the crop that will reach consumers as chocolate The solution not only tracks how the crops are growing, and ...

Healthcare and pharmaceuticals have the second largest exposure. Distributors such as McKesson Corp. and Cencora Inc. could face disruption, with the analysts noting government spending is related ...